The Effects of Single-dose Rectal Midazolam Application on Post-operative Recovery

NCT ID: NCT02127489

Last Updated: 2014-04-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-06-30

Study Completion Date

2006-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aimed to compare the efficiency of rectal midazolam addition after applying bupivacaine and caudal anesthesia on postoperative analgesia time, the need for additional analgesics, postoperative recovery, sedation, and to find out its adverse effects in children having lower abdominal surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Summary Background: This study aimed to compare the efficiency of rectal midazolam addition after applying bupivacaine and caudal anesthesia on postoperative analgesia time, the need for additional analgesics, postoperative recovery, sedation, and to find out its adverse effects in children having lower abdominal surgery.

Methods: 40 children between 2 and 10 years of American Society of Anesthesiologist (ASA) I-II stages were randomized and applied caudal anesthesia under general anesthesia. Patients were applied caudal block in addition with saline and 1milliliter/kilograms (mL/kg) bupivacaine 0.25%. In the postoperative period, Group C (n=20) was given 5 milliliter (mL) saline and Group M (n=20) was given 0.30 mg/kg rectal midazolam diluted with 5mL saline. Sedation scale and postoperative pain scale (CHIPPS) of the patients were evaluated. The patients were observed for their analgesic need, first analgesic time, and adverse effects for 24 hours.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Failed Moderate Sedation During Procedure

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Bupivacaine, caudal, rectal midazolam, children

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Midazolam

1 mL/kg bupivacaine 0.25%.

Group Type ACTIVE_COMPARATOR

1 mL/kg bupivacaine 0.25%.

Intervention Type DRUG

40 children between 2 and 10 years of ASA I-II were randomized and they received caudal anesthesia under general anesthesia. Patients underwent the application of caudal block in addition with saline and 1 mL/kg bupivacaine 0.25%. In the postoperative period, Group C (n=20) was given 5mL saline and Group M (n=20) was given 0.30 mg/kg rectal midazolam diluted with 5mL saline. Sedation scale and postoperative pain scale (CHIPPS) of the patients were evaluated. The patients were observed for their analgesic need, first analgesic time, and adverse effects for 24 hours.

saline

5mL rectal saline

Group Type PLACEBO_COMPARATOR

1 mL/kg bupivacaine 0.25%.

Intervention Type DRUG

40 children between 2 and 10 years of ASA I-II were randomized and they received caudal anesthesia under general anesthesia. Patients underwent the application of caudal block in addition with saline and 1 mL/kg bupivacaine 0.25%. In the postoperative period, Group C (n=20) was given 5mL saline and Group M (n=20) was given 0.30 mg/kg rectal midazolam diluted with 5mL saline. Sedation scale and postoperative pain scale (CHIPPS) of the patients were evaluated. The patients were observed for their analgesic need, first analgesic time, and adverse effects for 24 hours.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

1 mL/kg bupivacaine 0.25%.

40 children between 2 and 10 years of ASA I-II were randomized and they received caudal anesthesia under general anesthesia. Patients underwent the application of caudal block in addition with saline and 1 mL/kg bupivacaine 0.25%. In the postoperative period, Group C (n=20) was given 5mL saline and Group M (n=20) was given 0.30 mg/kg rectal midazolam diluted with 5mL saline. Sedation scale and postoperative pain scale (CHIPPS) of the patients were evaluated. The patients were observed for their analgesic need, first analgesic time, and adverse effects for 24 hours.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

AstraZeneca Marcaine

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* children having lower abdominal surgery

Exclusion Criteria

* Children with significant respiratory system, circulatory system, liver, and kidney function disorder, history of allergy to the drugs to be studied, those who received analgesic medication before the operation, and those for whom caudal anesthesia is contraindicated
Minimum Eligible Age

2 Years

Maximum Eligible Age

10 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Karadeniz Technical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

SEDAT SAYLAN

Medical Doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

SEDAT SAYLAN, Med. doctor

Role: PRINCIPAL_INVESTIGATOR

KANUNI EDUCATION AND RESEARCH HOSPITAL, TRABZON ,TURKEY

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Karadeniz Technical University Faculty of Medicine

Trabzon, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

References

Explore related publications, articles, or registry entries linked to this study.

Mahajan R, Batra YK, Grover VK, Kajal J. A comparative study of caudal bupivacaine and midazolam-bupivacaine mixture for post-operative analgesia in children undergoing genitourinary surgery. Int J Clin Pharmacol Ther. 2001 Mar;39(3):116-20. doi: 10.5414/cpp39116.

Reference Type BACKGROUND
PMID: 11396751 (View on PubMed)

Breschan C, Schalk HV, Schaumberger F, Likar R. Experience with caudal blocks in children over a period of 3.5 years. Acta Anaesthesiol Scand Suppl. 1996;109:174-6. No abstract available.

Reference Type BACKGROUND
PMID: 8901998 (View on PubMed)

Sumpelmann R, Munte S. Postoperative analgesia in infants and children. Curr Opin Anaesthesiol. 2003 Jun;16(3):309-13. doi: 10.1097/00001503-200306000-00011.

Reference Type BACKGROUND
PMID: 17021476 (View on PubMed)

Lee HM, Sanders GM. Caudal ropivacaine and ketamine for postoperative analgesia in children. Anaesthesia. 2000 Aug;55(8):806-10. doi: 10.1046/j.1365-2044.2000.01330-2.x.

Reference Type BACKGROUND
PMID: 10947698 (View on PubMed)

Silvani P, Camporesi A, Agostino MR, Salvo I. Caudal anesthesia in pediatrics: an update. Minerva Anestesiol. 2006 Jun;72(6):453-9.

Reference Type BACKGROUND
PMID: 16682915 (View on PubMed)

Clausen TG, Wolff J, Hansen PB, Larsen F, Rasmussen SN, Dixon JS, Crevoisier C. Pharmacokinetics of midazolam and alpha-hydroxy-midazolam following rectal and intravenous administration. Br J Clin Pharmacol. 1988 Apr;25(4):457-63. doi: 10.1111/j.1365-2125.1988.tb03330.x.

Reference Type BACKGROUND
PMID: 3382589 (View on PubMed)

Kanegaye JT, Favela JL, Acosta M, Bank DE. High-dose rectal midazolam for pediatric procedures: a randomized trial of sedative efficacy and agitation. Pediatr Emerg Care. 2003 Oct;19(5):329-36. doi: 10.1097/01.pec.0000092578.40174.85.

Reference Type BACKGROUND
PMID: 14578832 (View on PubMed)

McGrath PJ, McAlpine L. Psychologic perspectives on pediatric pain. J Pediatr. 1993 May;122(5 Pt 2):S2-8. doi: 10.1016/s0022-3476(11)80002-8.

Reference Type BACKGROUND
PMID: 8487132 (View on PubMed)

Tyler DC, Tu A, Douthit J, Chapman RC. Toward validation of pain measurement tools for children: a pilot study. Pain. 1993 Mar;52(3):301-309. doi: 10.1016/0304-3959(93)90163-J.

Reference Type BACKGROUND
PMID: 8460048 (View on PubMed)

Shavit I, Keidan I, Augarten A. The practice of pediatric procedural sedation and analgesia in the emergency department. Eur J Emerg Med. 2006 Oct;13(5):270-5. doi: 10.1097/00063110-200610000-00005.

Reference Type BACKGROUND
PMID: 16969231 (View on PubMed)

Roy RC. Choosing general versus regional anesthesia for the elderly. Anesthesiol Clin North Am. 2000 Mar;18(1):91-104, vii. doi: 10.1016/s0889-8537(05)70151-6.

Reference Type BACKGROUND
PMID: 10935002 (View on PubMed)

Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189-98. doi: 10.1016/0022-3956(75)90026-6. No abstract available.

Reference Type BACKGROUND
PMID: 1202204 (View on PubMed)

Somri M, Gaitini LA, Vaida SJ, Yanovski B, Sabo E, Levy N, Greenberg A, Liscinsky S, Zinder O. Effect of ilioinguinal nerve block on the catecholamine plasma levels in orchidopexy: comparison with caudal epidural block. Paediatr Anaesth. 2002 Nov;12(9):791-7. doi: 10.1046/j.1460-9592.2002.00916.x.

Reference Type BACKGROUND
PMID: 12519139 (View on PubMed)

Solak M, Ulusoy H, Sarihan H. Effects of caudal block on cortisol and prolactin responses to postoperative pain in children. Eur J Pediatr Surg. 2000 Aug;10(4):219-23. doi: 10.1055/s-2008-1072362.

Reference Type BACKGROUND
PMID: 11034509 (View on PubMed)

Golianu B, Krane EJ, Galloway KS, Yaster M. Pediatric acute pain management. Pediatr Clin North Am. 2000 Jun;47(3):559-87. doi: 10.1016/s0031-3955(05)70226-1.

Reference Type BACKGROUND
PMID: 10835991 (View on PubMed)

Martinez-Telleria A, Cano Serrano ME, Martinez-Telleria MJ, Castejon Casado J. [Analysis of regional anesthetic efficacy in pediatric postop pain]. Cir Pediatr. 1997 Jan;10(1):18-20. Spanish.

Reference Type BACKGROUND
PMID: 9131958 (View on PubMed)

Da Conceicao MJ, Coelho L. Caudal anaesthesia with 0.375% ropivacaine or 0.375% bupivacaine in paediatric patients. Br J Anaesth. 1998 Apr;80(4):507-8. doi: 10.1093/bja/80.4.507.

Reference Type BACKGROUND
PMID: 9640159 (View on PubMed)

Gann DS, Lilly MP. The neuroendocrine response to multiple trauma. World J Surg. 1983 Jan;7(1):101-18. doi: 10.1007/BF01655918. No abstract available.

Reference Type BACKGROUND
PMID: 6301162 (View on PubMed)

Kehlet H. The stress response to surgery: release mechanisms and the modifying effect of pain relief. Acta Chir Scand Suppl. 1989;550:22-8.

Reference Type BACKGROUND
PMID: 2652970 (View on PubMed)

Reier CE, George JM, Kilman JW. Cortisol and growth hormone response to surgical stress during morphine anesthesia. Anesth Analg. 1973 Nov-Dec;52(6):1003-10. No abstract available.

Reference Type BACKGROUND
PMID: 4357065 (View on PubMed)

Saylan S, Eroglu A, Dohman D. The effects of single-dose rectal midazolam application on postoperative recovery, sedation, and analgesia in children given caudal anesthesia plus bupivacaine. Biomed Res Int. 2014;2014:127548. doi: 10.1155/2014/127548. Epub 2014 May 5.

Reference Type DERIVED
PMID: 24883300 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://www.ncbi.nlm.nih.gov/pubmed

U.S. National Library of Medicine

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

B.30.2.KTU.0.01.00.01/372

Identifier Type: -

Identifier Source: org_study_id